Kalaris Therapeutics Inc. (KLRS)
Market is closed
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
- 1 - 5
- Next >>
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 12,948,081 | $109,281,804 | +14% | 11.27% |
| 2. | Paradigm Biocapital Advisors Senai Asefaw | 700,000 | $5,908,000 | 0.15% | |
| 3. | Siren L.L.C. Raymond Debbane | 435,798 | $3,678,135 | +37% | 0.11% |
| 4. | Alyeska Investment Group Anand Parekh | 403,551 | $3,402,109 | 0.01% | |
| 5. | Ikarian Capital Neil Shahrestani | 360,000 | $3,038,401 | 0.24% |
Hedge Fund Resource Center